The Army Drops Its Weed Ban, the FDA Drops the Hammer, and CBD Hits Medicare

The military, the feds, and your doctor's office are all adjusting to the same reality — cannabis is here to stay.

The United States military has never been known for moving fast on cultural shifts. But when the Army quietly rewrites its own rules on marijuana — and sets the effective date for 4/20 — you know the ground is shifting beneath everyone's feet.

This week brought a trifecta of federal-level cannabis moves that tell a much bigger story than any one headline. The Army is opening its doors to recruits with cannabis records. The FDA just submitted its first-ever CBD enforcement framework to the White House. And the Centers for Medicare and Medicaid Services is gearing up to let doctors recommend — and insurers cover — hemp-derived CBD for seniors.

All of this is happening while the Farm Bill threatens to ban most hemp THC products by November. Welcome to cannabis policy in 2026, where the left hand and the right hand are playing entirely different songs.

Let's break it down.

The Army Said 4/20. No, Really.

The U.S. Army has officially revised its recruiting regulations to remove the waiver requirement for applicants with a single marijuana possession or drug paraphernalia conviction. Under the old rules, a recruit with even one minor cannabis offense had to wait 24 months, pass a drug test at a Military Entrance Processing Station, and receive a waiver from Pentagon officials before enlisting.

That's gone now. Effective April 20, 2026 — yes, 4/20 — recruits with a single cannabis-related conviction can walk into a recruiting office and sign up without jumping through any of those hoops.

The timing is coincidental, but the symbolism writes itself. The Army is also raising its maximum enlistment age from 35 to 42, bringing it in line with the Navy and Air Force. Both moves are part of a multi-billion-dollar recruiting overhaul launched after the Army missed its 2022 target by roughly 15,000 recruits.

Kate Kuzminski, a military recruitment expert at the Center for a New American Security, put it plainly: the change "accounts for changes in society." With nearly half of U.S. states now allowing recreational cannabis, requiring Pentagon-level waivers for a single joint was costing the Army qualified candidates.

The broader context matters, too. Only about 23 percent of young Americans currently qualify for military service without a waiver. Anything the Army can do to reduce bureaucratic friction — especially for minor, nonviolent offenses — keeps potential recruits from walking away during the months-long waiver process.

For the Weedcoin community, this is another brick in the wall. The federal government's own military branch is acknowledging what the culture already knows: a cannabis conviction should not define your future.

The FDA Finally Has a CBD Plan — And It's Coming for Everyone



For nearly eight years since the 2018 Farm Bill legalized hemp, the CBD industry has operated in what regulators politely call "enforcement discretion" and what everyone else calls the Wild West. That era appears to be ending.

On March 13, the Food and Drug Administration submitted a document titled "Cannabidiol (CBD) Products Compliance and Enforcement Policy" to the White House Office of Information and Regulatory Affairs for review. This is the first concrete federal framework for CBD regulation since hemp was legalized.

The full text hasn't been published yet, but based on the FDA's track record of warning letters and public statements, the policy is expected to focus on three areas.

First, health claims. The FDA has always maintained that you can't market CBD as a treatment for anxiety, pain, or sleep disorders without going through the drug approval process. The new policy is expected to crack down not just on label claims, but on "implied" claims found in blog posts, social media, and even website meta tags.

Second, manufacturing standards. The FDA wants to see Current Good Manufacturing Practices across the board — meaning every CBD product needs verifiable testing for contaminants like heavy metals, pesticides, and residual solvents, and the actual CBD content has to match the label.

Third, the dietary supplement question. Whether CBD can legally be marketed as a supplement has been a central debate since 2018. The new policy may open a pathway for CBD as a New Dietary Ingredient, but with strict safety data requirements.

For an industry that's largely been self-regulating, this is a wake-up call. But it's also a sign of maturity. Clear rules of the road tend to benefit the companies doing things right and weed out — no pun intended — the ones cutting corners.